Search
for
Sort by
Research 481–510 of 1000+
- Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy
- Patient-reported outcomes of adverse events after perioperative chemotherapy for breast cancer: A prospective observational study
- Increased blood level of urea and creatinine after chemotherapy in breast cancer patients
- The Application Progress of Tumor Microenvironment-Responsive Drug Carriers in Precision Chemotherapy
- Symptom Experience of Lung Cancer Patients Treated With Immunotherapy Combined with Chemotherapy: A Longitudinal Study
- Effectiveness and Safety Profile of Cisplatin Versus Nab-Paclitaxel Concomitant Chemoradiotherapy in Postoperative Early-Stage Cancer of Cervix
- Symptom Experience and Coping Strategies Among Patients with Breast Cancer Receiving Chemotherapy
- Uniform boundedness and asymptotic behavior of solutions in a chemotaxis model for alopecia areata
- S-l Combined with Paclitaxel as Second-line Chemotherapy for Advanced Gastric Cancer
- Outcomes Associated With the Use of Finasteride: An Evaluation of this Medication as a Chemoprotective Agent and its Efficacy
- Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
- Influence of <i>FHIT</i> on benzo[ <i>a</i> ]pyrene-induced tumors and alopecia in mice: Chemoprevention by budesonide and <i>N</i> -acetylcysteine
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- A Pilot Study of a Grape Seed Procyanidin Extract for Lung Cancer Chemoprevention
- A Clinical Evaluation of Guduchi (Tinospora cordifolia) and Yashtimadhu (Glycyrrhiza glabra) as Chemopreventive Agent in Cancer Treatment
- Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968)
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
- Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
- The manipulation of the cedrol metabolism pathway by baricitinib and its immune interaction mechanism against chemotherapy-induced alopecia
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Role of Herbomineral Drugs in the Management of Diarrhea and Late Effects of Chemotherapy in the Patient of Oral Cavity Cancer
- SKIN TARGETING OF AN OPTIMIZED CAFFEINE NANOSTRUCTURED LIPID CARRIER WITH IMPROVED EFFICIENCY AGAINST CHEMOTHERAPY INDUCED ALOPECIA
- Skin Targeting of An Optimized Caffeine Nanostructured Lipid Carrier With Improved Efficiency Against Chemotherapy Induced Alopecia
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Crude extracts and essential oil of Platycladus orientalis (L.) Franco: a source of phenolics with antioxidant and antibacterial potential as assessed through a chemometric approach
- Enzyme-triggered on-demand release of a H<sub>2</sub>O<sub>2</sub>-self-supplying CuO<sub>2</sub>@Fe<sub>3</sub>O<sub>4</sub> nanoagent for enhanced chemodyamic antimicrobial therapy and wound healing